UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7201
DELISTED
STRATUS PPTYS INC
STRS
| $83.5K | ﹤0.01% |
2,904
-3,005
| -51% | -$88.4K |
2014 Q4
46 quarters
|
|
7202
EuroDry
EDRY
$99.2M
| $83.2K | ﹤0.01% |
+3,801
| New | +$82.1K |
2026 Q2
0 quarters
|
|
7203
IceCure Medical
ICCM
$3.16M
| $83.1K | ﹤0.01% |
17,093
+11,953
| +233% | +$86.4K |
2025 Q1
5 quarters
|
|
7204
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$650M
| $83.1K | ﹤0.01% |
847
+82
| +11% | +$8.14K |
2017 Q3
35 quarters
|
|
7205
DELISTED
Voya Asia Pacific High Dividend Equity Income Fund
IAE
| $82.8K | ﹤0.01% |
8,937
-2,531
| -22% | -$21.2K |
2014 Q4
46 quarters
|
|
7206
OKYO Pharma
OKYO
$75M
| $82.5K | ﹤0.01% |
55,009
-4,751
| -8% | -$7.61K |
2025 Q4
2 quarters
|
|
7207
FitLife Brands
FTLF
$74.9M
| $82.2K | ﹤0.01% |
7,466
+4,377
| +142% | +$44.2K |
2024 Q4
6 quarters
|
|
7208
U.S. Vector Equity Portfolio ETF Class Shares
DXUV
$579M
| $82.2K | ﹤0.01% |
1,236
+991
| +404% | +$63.9K |
2026 Q1
1 quarter
|
|
7209
vTv Therapeutics
VTVT
$83.2M
| $81.9K | ﹤0.01% |
2,175
-3,461
| -61% | -$120K |
2024 Q1
9 quarters
|
|
7210
Franklin Covey
FC
$183M
| $81.9K | ﹤0.01% |
3,337
-6,994
| -68% | -$159K |
2018 Q2
32 quarters
|
|
7211
BrasilAgro
LND
$325M
| $81.5K | ﹤0.01% |
22,825
+152
| +0.7% | +$583 |
2024 Q4
6 quarters
|
|
7212
FIGX Capital Acquisition Corp
FIGX
$201M
| $81.3K | ﹤0.01% |
+7,952
| New | +$81.2K |
2026 Q2
0 quarters
|
|
7213
Rail Vision
RVSN
$6.34M
| $81.3K | ﹤0.01% |
17,646
-8,293
| -32% | -$52.6K |
2024 Q3
7 quarters
|
|
7214
First Bancorp
FNLC
$411M
| $81.3K | ﹤0.01% |
2,336
-2,667
| -53% | -$79.2K |
2014 Q4
46 quarters
|
|
7215
Air Industries Group
AIRI
$13.6M
| $81.3K | ﹤0.01% |
26,929
+2,602
| +11% | +$7.98K |
2024 Q2
8 quarters
|
|
7216
Invesco Oil & Gas Services ETF
PXJ
$118M
| $81.2K | ﹤0.01% |
2,105
-1,157
| -35% | -$49.8K |
2014 Q4
46 quarters
|
|
7217
PUT
Samsara
IOT
$24B
| $81.1K | ﹤0.01% |
+2,500
| New | +$77.4K |
2026 Q2
0 quarters
|
|
7218
Lionheart Holdings Unit
CUBWU
| $81K | ﹤0.01% |
7,447
| – | – |
2024 Q2
8 quarters
|
|
7219
Niu Technologies
NIU
$142M
| $80.9K | ﹤0.01% |
40,255
-16,571
| -29% | -$43.9K |
2020 Q1
25 quarters
|
|
7220
Sow Good
SOWG
$45.4M
| $80.8K | ﹤0.01% |
19,380
+17,783
| +1,114% | +$47.5K |
2024 Q4
6 quarters
|
|
7221
Portfolio Building Block World Pharma and Biotech Index ETF
PBPH
$1.09B
| $80.7K | ﹤0.01% |
2,970
+1,126
| +61% | +$28.7K |
2026 Q1
1 quarter
|
|
7222
Ioneer
IONR
$200M
| $80.6K | ﹤0.01% |
18,606
-91,002
| -83% | -$368K |
2024 Q3
7 quarters
|
|
7223
Innovator Equity Dual Directional 15 Buffer ETF - January
DDFJ
$74.7M
| $80.6K | ﹤0.01% |
4,075
+3,431
| +533% | +$66.9K |
2026 Q1
1 quarter
|
|
7224
DELISTED
Affinity Bancshares
AFBI
| $79.6K | ﹤0.01% |
3,524
+2,512
| +248% | +$56.4K |
2024 Q1
9 quarters
|
|
7225
Silver Bow Mining Corp
SBMT
$163M
| $79.5K | ﹤0.01% |
+11,765
| New | +$104K |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.